Kuleana Technology

Kuleana Technology

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Kuleana Technology is a private, pre-revenue startup founded in 2020 to address the significant burdens of conventional in-center dialysis. The company is advancing a dual-technology platform: a portable, water-efficient dialysis machine developed at the University of Washington's Center for Dialysis Innovation (CDI), and a complementary needleless vascular access system. By untethering patients from clinic-based treatment and eliminating painful needle sticks, Kuleana aims to enable more frequent, convenient, and tolerable dialysis, potentially improving patient quality of life and clinical outcomes. The company maintains strong research partnerships with leading renal care institutions in the Pacific Northwest.

NephrologyEnd-Stage Renal Disease

Technology Platform

Dual-platform comprising: 1) A portable, closed-loop dialysis system that regenerates dialysate, eliminating need for continuous water supply; and 2) A needleless vascular access technology for pain-free connection to the bloodstream.

Opportunities

The large and growing global dialysis market is incentivizing a shift to home-based care, for which Kuleana's portable and patient-friendly technologies are uniquely suited.
Successful development could enable more frequent dialysis, which is clinically associated with better patient outcomes and lower long-term healthcare costs, creating strong value-based reimbursement arguments.

Risk Factors

The company faces significant technical hurdles in miniaturizing dialysis technology and creating a reliable needleless access system, followed by a lengthy and costly FDA regulatory pathway.
Commercial adoption risks include overcoming clinician inertia, patient comfort with new technology, and competition from large, entrenched dialysis providers.

Competitive Landscape

Kuleana competes in the dialysis equipment and vascular access markets, dominated by large players like Fresenius and Baxter. Its direct competitors include other startups developing portable/wearable artificial kidneys (e.g., AWAK, NxStage prior to acquisition) and companies working on needleless access devices. Kuleana's differentiation is the potential combination of portability with pain-free access in an integrated system.